Skip to main content
Top
Published in: BMC Cancer 1/2020

01-12-2020 | Human Papillomavirus | Research article

Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression

Authors: Maria Teresa Bruno, Guido Scalia, Nazario Cassaro, Sara Boemi

Published in: BMC Cancer | Issue 1/2020

Login to get access

Abstract

Background

We studied the cases of single and multiple HPV infection and analyzed the correlation with negative cases, and preneoplastic and neoplastic lesions of the uterine cervix with the aim of making a contribution to the prognostic factor under discussion.

Methods

Nine hundred nine women undergoing second level screening because they had been positive at cervical cytology were enrolled.
All the patients underwent colposcopy and cervical biopsy with viral genotyping. We divided mHPV infection based on the number of genotypes present: infections with 2 strains, 3 strains, 4 strains and 5 or more strains.

Statistical analysis

The analysis of the data was made using the χ2 test. Contingency tables were created to evaluate the correlation between single, multiple and CIN2+ infections. Values with p < 0.05 were considered statistically significant.

Results

The presence of genotype HPV16 in our study was associated with a 12 times greater risk of developing a high-grade lesion, OR = 12.70. The patients with single infections had the highest incidence of CIN2+ (34.1%) with respect to those with multiple infections (10.6%).When we studied in the mHPV infection the prevalence of the combinations between the genotypes, we found that in mHPV16 infections, the combinations HPV16, 18 and HPV16, 31 were the most frequent (55.5%) in CIN3 lesion.

Conclusions

Our results suggest that single HPV infections have a greater risk of developing SCC with respect to multiple infections. Multiple HPV infections are relevant only in the first phase of the lesion (CIN1-CIN2), while they are absent in carcinomas, where infections are of a single genotype. In particular, among multiple infections, HPV16 infection with 2 HR genotypes is associated significantly with CIN2 / CIN3 (21/30) and has 4 times greater risk of developing a high-grade lesion. Thus, it is probable that only specific combinations of HPV (HPV16,18 - HPV 16,31) can be associated with a clinically significant impact, while other combinations can simply be correlated because of a common infection or diagnostic method used. Therefore, multiple HPV16 infections with two high-risk genotypes is a major risk of CIN2/CIN3.
Literature
1.
go back to reference Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRef Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.CrossRef
2.
go back to reference Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomark Prev. 2006;15(7):1274–80.CrossRef Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomark Prev. 2006;15(7):1274–80.CrossRef
3.
go back to reference Bruno, M. T, Ferrara, M, Fava, V, Barrasso, G., Cutello, S., Sapia, F., Panella, M.M. Prevalence genotypes and distribution of human papillomavirus infection in women with abnormal cervical cytology in Catania, Italy. Giornale Italiano di Ostetricia e Ginecologia Volume 38, Issue 5–6, September–December 2016, Pages 376–380. Bruno, M. T, Ferrara, M, Fava, V, Barrasso, G., Cutello, S., Sapia, F., Panella, M.M. Prevalence genotypes and distribution of human papillomavirus infection in women with abnormal cervical cytology in Catania, Italy. Giornale Italiano di Ostetricia e Ginecologia Volume 38, Issue 5–6, September–December 2016, Pages 376–380.
4.
go back to reference Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classificationof human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.CrossRef Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classificationof human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.CrossRef
5.
go back to reference Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14.CrossRef Paavonen J, Naud P, Salmerón J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14.CrossRef
6.
go back to reference Campos NG, et al. Persistence of concurrent infections with multiple human -papillomavirus types: a population based cohort study. J Infect Dis. 2011;203:823–7.CrossRef Campos NG, et al. Persistence of concurrent infections with multiple human -papillomavirus types: a population based cohort study. J Infect Dis. 2011;203:823–7.CrossRef
7.
go back to reference Liaw KL, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2001;183:8–15.CrossRef Liaw KL, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2001;183:8–15.CrossRef
8.
go back to reference Chaturvedi AK, et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomark Prev. 2005;14:2439–45.CrossRef Chaturvedi AK, et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomark Prev. 2005;14:2439–45.CrossRef
9.
go back to reference Herrero R. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. J Infect Dis. 2009;199:919–22.CrossRef Herrero R. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. J Infect Dis. 2009;199:919–22.CrossRef
10.
go back to reference Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Me Virol. 2001;64:550–9.CrossRef Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Me Virol. 2001;64:550–9.CrossRef
11.
go back to reference Bosch FX, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.CrossRef Bosch FX, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.CrossRef
12.
go back to reference Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGooganJ E. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. Clin Pathol. 2004;57:68–72.CrossRef Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGooganJ E. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. Clin Pathol. 2004;57:68–72.CrossRef
13.
go back to reference Becker TM, Wheeler CM, McGrough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA. 1994;271:1181–8.CrossRef Becker TM, Wheeler CM, McGrough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA. 1994;271:1181–8.CrossRef
14.
go back to reference Rousseau MC, Pereira JS, Prado JCM, et al. Cervical coinfection with human papillomavirus types as a predictor of acquisition and persistence of HPV infection. J Infect Dis. 2001;184:1508–17.CrossRef Rousseau MC, Pereira JS, Prado JCM, et al. Cervical coinfection with human papillomavirus types as a predictor of acquisition and persistence of HPV infection. J Infect Dis. 2001;184:1508–17.CrossRef
15.
go back to reference Rolon PA, Smith JS, Muñoz N, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer. 2000;85:486–91.CrossRef Rolon PA, Smith JS, Muñoz N, et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer. 2000;85:486–91.CrossRef
16.
go back to reference Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol. 2002;9:3341–5.CrossRef Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol. 2002;9:3341–5.CrossRef
17.
go back to reference Klug SJ, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types, J Med Virol. 2008; vol. 80 (pg. 1264–1274). Klug SJ, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types, J Med Virol. 2008; vol. 80 (pg. 1264–1274).
18.
go back to reference Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89:101–5.CrossRef Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89:101–5.CrossRef
19.
go back to reference Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88:63–73.CrossRef Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88:63–73.CrossRef
20.
go back to reference Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621–32.CrossRef Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621–32.CrossRef
21.
go back to reference Koshiol J, Lindsay L, Pimenta JM, et al. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:123–37.CrossRef Koshiol J, Lindsay L, Pimenta JM, et al. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:123–37.CrossRef
22.
go back to reference Soto-De LS, et al. Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One. 2011;6(2):e14705.CrossRef Soto-De LS, et al. Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One. 2011;6(2):e14705.CrossRef
23.
go back to reference Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. One virus, one lesion—individual components of CIN lesions contain a specific HPV type the journal of pathology. Volume. 2012;227:62–7. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. One virus, one lesion—individual components of CIN lesions contain a specific HPV type the journal of pathology. Volume. 2012;227:62–7.
24.
go back to reference Bruno MT, Ferrara M, Fava V, Rapisarda A, Coco A. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women. Virol J. 2018;15:52–6.CrossRef Bruno MT, Ferrara M, Fava V, Rapisarda A, Coco A. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women. Virol J. 2018;15:52–6.CrossRef
Metadata
Title
Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression
Authors
Maria Teresa Bruno
Guido Scalia
Nazario Cassaro
Sara Boemi
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2020
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-020-06946-7

Other articles of this Issue 1/2020

BMC Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine